dc.contributor.author |
Thimiri Govindaraj, Deepak B
|
|
dc.date.accessioned |
2021-12-06T09:03:24Z |
|
dc.date.available |
2021-12-06T09:03:24Z |
|
dc.date.issued |
2021-11 |
|
dc.identifier.citation |
Thimiri Govindaraj, D.B. 2021. Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine. <i>Hematology, Transfusion and Cell Therapy.</i> http://hdl.handle.net/10204/12193 |
en_ZA |
dc.identifier.issn |
2531-1379 |
|
dc.identifier.issn |
2531-1387 |
|
dc.identifier.uri |
https://doi.org/10.1016/j.htct.2021.10.1022
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/12193
|
|
dc.description.abstract |
Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients. |
en_US |
dc.format |
Fulltext |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.uri |
https://www.sciencedirect.com/science/article/pii/S253113792101169X?via%3Dihub |
en_US |
dc.source |
Hematology, Transfusion and Cell Therapy |
en_US |
dc.subject |
Drug discovery |
en_US |
dc.subject |
Cancer |
en_US |
dc.subject |
South African Leukemia patients |
en_US |
dc.title |
Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine |
en_US |
dc.type |
Article |
en_US |
dc.description.pages |
37-38 |
en_US |
dc.description.note |
Published under a Creative Commons license |
en_US |
dc.description.cluster |
Next Generation Health |
en_US |
dc.description.impactarea |
Synthetic Nanobiotech Biomachs |
en_US |
dc.identifier.apacitation |
Thimiri Govindaraj, D. B. (2021). Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine. <i>Hematology, Transfusion and Cell Therapy</i>, http://hdl.handle.net/10204/12193 |
en_ZA |
dc.identifier.chicagocitation |
Thimiri Govindaraj, Deepak B "Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine." <i>Hematology, Transfusion and Cell Therapy</i> (2021) http://hdl.handle.net/10204/12193 |
en_ZA |
dc.identifier.vancouvercitation |
Thimiri Govindaraj DB. Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine. Hematology, Transfusion and Cell Therapy. 2021; http://hdl.handle.net/10204/12193. |
en_ZA |
dc.identifier.ris |
TY - Article
AU - Thimiri Govindaraj, Deepak B
AB - Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients.
DA - 2021-11
DB - ResearchSpace
DP - CSIR
J1 - Hematology, Transfusion and Cell Therapy
KW - Drug discovery
KW - Cancer
KW - South African Leukemia patients
LK - https://researchspace.csir.co.za
PY - 2021
SM - 2531-1379
SM - 2531-1387
T1 - Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine
TI - Synthetic biology meets precision medicine: Drug repurposing for bloodcancer precision medicine
UR - http://hdl.handle.net/10204/12193
ER - |
en_ZA |
dc.identifier.worklist |
25128 |
en_US |